Eribulin mesylate (halichondrin B Analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a two-cohort, phase II study

BACKGROUND: Eribulin mesylate is a tubulin inhibitor with activity superior to paclitaxel in NIH:OVCAR-3 human epithelial ovarian cancer xenograft models. We sought to assess the efficacy of eribulin in platinum-resistant and platinum-sensitive recurrent ovarian cancer. METHODS: Patients with recurr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hensley, Martee L., Kravetz, Sara, Jia, Xiaoyu, Iasonos, Alexia, Tew, William, Pereira, Lauren, Sabbatini, Paul, Whalen, Christin, Aghajanian, Carol A., Zarwan, Corinne, Berlin, Suzanne
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3245795/
https://ncbi.nlm.nih.gov/pubmed/21935916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26569
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares